← Evidence map

ArticleBritish journal of pharmacology2015

Preclinical development of AMG 139, a human antibody specifically targeting IL-23.

K Köck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25205227